According to the findings of the SELECT trial (The Selenium and Vitamin E Cancer Prevention Trial) published in the 12th October 2011 issue of JAMA (Journal of the American Medical Association), vitamin E supplementation of 400 IU per day may carry a 17% increased risk for prostate cancer.